Omega-3 PUFA-gene interaction in prostate cancer

Omega-3 PUFA 与前列腺癌中基因的相互作用

基本信息

  • 批准号:
    8434839
  • 负责人:
  • 金额:
    $ 33.56万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2012
  • 资助国家:
    美国
  • 起止时间:
    2012-03-01 至 2017-02-28
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): We have previously shown that I3 PUFA reduced prostate cancer (PCa) growth, slowed histopathological progression and increased survival, whereas I6 PUFA had the opposite effects. To systematically assess the interaction between oxygenases and PUFAs in PCa, we knocked out Cox1, Cox2, Lox5, Lox12, and Lox15 in prostate-specific Pten-null mice. Our results indicate a complex PUFA-gene interaction in PCa: (a) Loss of Cox1 had significant effects on PCa growth in a PUFA-dependent manner; namely, tumor growth was significantly diminished in Cox1 knockout mice on I6 diet, whereas it increased in mice on I3 diet. In other words, Cox1 was required for the protective effects of I3 PUFA, suggesting that I3 metabolites of Cox1 (e.g. PGE3) are involved. On the other hand, I6 metabolites of Cox1 (e.g. PGE2) play a promoting role on tumor formation. (b) Loss of Cox2 reduced PCa growth on both I6 and I3 diet. Therefore, I6 metabolites of Cox2 promote tumor growth, and suppressive effects of I3 PUFA do not depend upon Cox2. (c) Loss of Lox5 reduced PCa growth on I6 diet but had no effect on I3 diet, suggesting that I6 metabolites of Lox5 (e.g. LTB4) promote tumor growth, and protective effects of I3 PUFA are independent of Lox5. (d) Loss of Lox12 or Lox15 did not affect PCa growth, suggesting that these two enzymes are not critical for PCa in our model. We hypothesize that I3 PUFA is primarily metabolized by Cox1 in vivo and that the anti-proliferative effect of I3 PUFA is, in part, mediated by Cox1 metabolite(s). Furthermore, I6 PUFA is metabolized by Cox1, Cox2 and Lox5, and the corresponding metabolites play important roles in stimulating PCa growth. To test our hypothesis, three specific aims are proposed: (1) Study the cellular mechanism(s) of PUFA-gene interaction on PCa growth, (2) Identify metabolite(s) of I3 and I6 PUFA important in PCa and (3) Examine metabolite signaling in PCa cell proliferation and apoptosis.
描述(由申请人提供):我们之前的研究表明,I3 PUFA可以降低前列腺癌(PCa)的生长,减缓组织病理进展,提高生存率,而I6 PUFA具有相反的效果。为了系统地评估PCa中加氧酶和PUFAs之间的相互作用,我们在前列腺特异性pten缺失小鼠中敲除了Cox1、Cox2、Lox5、Lox12和Lox15。我们的研究结果表明,PCa中存在复杂的pufa -基因相互作用:(a) Cox1的缺失以pufa依赖的方式对PCa的生长有显著影响;即,I6组Cox1基因敲除小鼠的肿瘤生长明显减弱,而I3组小鼠的肿瘤生长则增加。换句话说,I3 PUFA的保护作用需要Cox1,这表明Cox1的I3代谢物(如PGE3)参与其中。另一方面,Cox1的I6代谢产物(如PGE2)在肿瘤形成中起促进作用。(b) Cox2的缺失降低了I6和I3日粮中PCa的生长。因此,Cox2的I6代谢产物促进肿瘤生长,I3 PUFA的抑制作用不依赖于Cox2。(c) Lox5的缺失降低了I6日粮中PCa的生长,但对I3日粮没有影响,说明I6中Lox5的代谢物(如LTB4)促进肿瘤生长,I3 PUFA的保护作用不依赖于Lox5。(d) Lox12或Lox15的缺失不影响PCa的生长,这表明在我们的模型中,这两种酶对PCa并不重要。我们假设I3 PUFA在体内主要由Cox1代谢,I3 PUFA的抗增殖作用部分是由Cox1代谢物介导的。此外,I6 PUFA被Cox1、Cox2和Lox5代谢,相应的代谢物在刺激PCa生长中起重要作用。为了验证我们的假设,我们提出了三个特定的目标:(1)研究PUFA-基因相互作用对PCa生长的细胞机制;(2)鉴定在PCa中重要的I3和I6 PUFA的代谢物;(3)研究代谢物信号在PCa细胞增殖和凋亡中的作用。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

YONG Q CHEN其他文献

YONG Q CHEN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('YONG Q CHEN', 18)}}的其他基金

Omega-3 PUFA-gene interaction in prostate cancer
Omega-3 PUFA 与前列腺癌中基因的相互作用
  • 批准号:
    8215565
  • 财政年份:
    2012
  • 资助金额:
    $ 33.56万
  • 项目类别:
Omega-3 PUFA-gene interaction in prostate cancer
Omega-3 PUFA 与前列腺癌中基因的相互作用
  • 批准号:
    8607164
  • 财政年份:
    2012
  • 资助金额:
    $ 33.56万
  • 项目类别:
Omega-3 PUFA-gene interaction in prostate cancer
Omega-3 PUFA 与前列腺癌中基因的相互作用
  • 批准号:
    8815275
  • 财政年份:
    2012
  • 资助金额:
    $ 33.56万
  • 项目类别:
North Carolina A&T University-Wake Forest Cancer Center partnership (2 of 2)
北卡罗来纳州A
  • 批准号:
    8135336
  • 财政年份:
    2008
  • 资助金额:
    $ 33.56万
  • 项目类别:
Microarray Core
微阵列核心
  • 批准号:
    7529756
  • 财政年份:
    2007
  • 资助金额:
    $ 33.56万
  • 项目类别:
Effect of Dietary Omega-3 Fatty Acid Supplement on Prostate Cancer Metastasis
膳食 Omega-3 脂肪酸补充剂对前列腺癌转移的影响
  • 批准号:
    7176369
  • 财政年份:
    2007
  • 资助金额:
    $ 33.56万
  • 项目类别:
Effect of Dietary Omega-3 Fatty Acid Supplement on Prostate Cancer Metastasis
膳食 Omega-3 脂肪酸补充剂对前列腺癌转移的影响
  • 批准号:
    7393162
  • 财政年份:
    2007
  • 资助金额:
    $ 33.56万
  • 项目类别:
Administrative/Biostatistics Core
行政/生物统计核心
  • 批准号:
    7152263
  • 财政年份:
    2006
  • 资助金额:
    $ 33.56万
  • 项目类别:
Mechanism of Fish Oil Supplements in Prevention of Cance
鱼油补充剂预防癌症的机制
  • 批准号:
    7136894
  • 财政年份:
    2006
  • 资助金额:
    $ 33.56万
  • 项目类别:
Anti-cancer mechanisms of n-3 PUFA mediated by syndecan
Syndecan介导的n-3 PUFA抗癌机制
  • 批准号:
    7152260
  • 财政年份:
    2006
  • 资助金额:
    $ 33.56万
  • 项目类别:

相似海外基金

How angiogenic factor induces immunosuppressive cells to tumor microenvironment
血管生成因子如何诱导免疫抑制细胞进入肿瘤微环境
  • 批准号:
    22KJ0818
  • 财政年份:
    2023
  • 资助金额:
    $ 33.56万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Validation of Adenylosuccinate as a Novel Endogenous Pro-Angiogenic Factor in the Brain
腺苷琥珀酸作为大脑中新型内源性促血管生成因子的验证
  • 批准号:
    10711027
  • 财政年份:
    2021
  • 资助金额:
    $ 33.56万
  • 项目类别:
Validation of Adenylosuccinate as a Novel Endogenous Pro-Angiogenic Factor in the Brain
腺苷琥珀酸作为大脑中新型内源性促血管生成因子的验证
  • 批准号:
    10297199
  • 财政年份:
    2021
  • 资助金额:
    $ 33.56万
  • 项目类别:
Validation of Adenylosuccinate as a Novel Endogenous Pro-Angiogenic Factor in the Brain
腺苷琥珀酸作为大脑中新型内源性促血管生成因子的验证
  • 批准号:
    10625314
  • 财政年份:
    2021
  • 资助金额:
    $ 33.56万
  • 项目类别:
Validation of Adenylosuccinate as a Novel Endogenous Pro-Angiogenic Factor in the Brain
腺苷琥珀酸作为大脑中新型内源性促血管生成因子的验证
  • 批准号:
    10405070
  • 财政年份:
    2021
  • 资助金额:
    $ 33.56万
  • 项目类别:
Physiological role of anti-angiogenic factor thrombospondin in the regulation of endometrial function during early pregnancy in cattle
抗血管生成因子血小板反应蛋白在牛妊娠早期子宫内膜功能调节中的生理作用
  • 批准号:
    20K06385
  • 财政年份:
    2020
  • 资助金额:
    $ 33.56万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Elucidation of lymphangiogenic regulatory mechanism of angiogenic factor CCN2 through tumor-associated macrophage
阐明血管生成因子CCN2通过肿瘤相关巨噬细胞的淋巴管生成调节机制
  • 批准号:
    17K11866
  • 财政年份:
    2017
  • 资助金额:
    $ 33.56万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Elucidation of vascular stabilization mechanism by anti-angiogenic factor vasohibin-1
抗血管生成因子 vasohibin-1 阐明血管稳定机制
  • 批准号:
    15K20874
  • 财政年份:
    2015
  • 资助金额:
    $ 33.56万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
angiogenic therapy for cerebral infarction with anti^sense homology derived peptide targeting angiogenic factor
靶向血管生成因子的反义同源肽治疗脑梗死
  • 批准号:
    15K15523
  • 财政年份:
    2015
  • 资助金额:
    $ 33.56万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
The development of the anti-angiogenic factor VEGF-A165b quantification methods for cardiovascular disease.
心血管疾病抗血管生成因子 VEGF-A165b 定量方法的开发。
  • 批准号:
    26860367
  • 财政年份:
    2014
  • 资助金额:
    $ 33.56万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了